Weill Cornell Medicine was awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from NCI to improve the detection, diagnosis and treatment of prostate cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
